NCT02496065View on ClinicalTrials.gov

Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Tumors, Breast
Interventions
DRUG

BLZ-100

Trial Locations (2)

98004

Overlake Medical Center, Bellevue

98195

University of Washington Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Blaze Bioscience Inc.

INDUSTRY